Clinical usefulness of virulence factors of Helicobacter pylori as predictors of the outcomes of infection. What is the evidence?
González
C A
CA
Dept. of Epidemiology, Catalan Institute of Oncology, Barcelona, Spain.
Peña
S
S
Capellá
G
G
D018829:Adhesins, Bacterial / Q000235:genetics; D000942:Antigens, Bacterial / Q000235:genetics*; D001426:Bacterial Proteins / Q000235:genetics*; D002352:Carrier Proteins / Q000235:genetics; D004381:Duodenal Ulcer / Q000209:etiology / Q000382:microbiology; D015870:Gene Expression; D005838:Genotype; D016481:Helicobacter Infections / Q000150:complications / Q000453:epidemiology*; D016480:Helicobacter pylori / Q000235:genetics* / Q000472:pathogenicity; D006801:Humans; D013276:Stomach Ulcer / Q000209:etiology* / Q000382:microbiology; D014774:Virulence / Q000235:genetics
D018829:Adhesins, Bacterial; D000942:Antigens, Bacterial; C400429:BabA protein, Helicobacter pylori; D001426:Bacterial Proteins; D002352:Carrier Proteins; C074689:VacA protein, Helicobacter pylori; C080866:cagA protein, Helicobacter pylori